Metaplastic breast carcinomas are basal-like tumours

被引:264
作者
Reis-Filho, J. S.
Milanezi, F.
Steele, D.
Savage, K.
Simpson, P. T.
Nesland, J. M.
Pereira, E. M.
Lakhani, S. R.
Schmitt, F. C.
机构
[1] Inst Canc Res, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England
[2] Univ Minho, Sch Hlth Sci, ICVS, Life & Hlth Sci Res Inst, Braga, Portugal
[3] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal
[4] Univ Queensland, Mayne Med Sch, Med Res Inst, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[6] Univ Oslo, Norwegian Radium Hosp, Montebello, Norway
[7] Lab Salomao & Zoppi, Sao Paulo, Brazil
[8] Univ Porto, Fac Med, Oporto, Portugal
关键词
carcinosarcoma; epidermal growth factor receptor (HER1); immunohistochemistry; myoepithelial; sarcomatoid carcinoma;
D O I
10.1111/j.1365-2559.2006.02467.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: Recently, an immunohistochemical panel comprising antibodies against HER2, oestrogen receptor (ER), epidermal growth factor receptor (EGFR) and cytokeratin (CK) 5/6 was reported to identify basal-like breast carcinomas, as defined by cDNA microarrays. Our aim was to analyse a series of metaplastic breast carcinomas (MBCs) using this panel plus two other basal markers (CK14 and p63) and progesterone receptor (PR), to define how frequently MBCs show a basal-like immunophenotype. Methods and results: Sixty-five cases were retrieved from the pathology archives of the authors' institutions and reviewed by three of the authors. Immunohistochemistry with antibodies for HER2, ER, EGFR, CK5/6, CK14 and p63 was performed according to standard methods. All but six cases (91%) showed the typical immunoprofile of basal-like tumours (ER- and HER2-, EGFR+ and/or CK5/6+). When CK14 and p63 were added to the panel, two additional cases could be classified as basal-like. The majority of MBCs lacked PR, except 4/19 (21%) carcinomas with squamous metaplasia. Conclusions: Our results demonstrate that MBCs show a basal-like phenotype, regardless of the type of metaplastic elements. Moreover, as these neoplasms frequently overexpress EGFR (57%), patients with MBC may benefit from treatment with anti-EGFR drugs.
引用
收藏
页码:10 / 21
页数:12
相关论文
共 47 条
[1]   High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses [J].
Abd El-Rehim, DM ;
Ball, G ;
Pinder, SE ;
Rakha, E ;
Paish, C ;
Robertson, JFR ;
Macmillan, D ;
Blamey, RW ;
Ellis, IO .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :340-350
[2]   Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients [J].
Adem, C ;
Reynolds, C ;
Adlakha, H ;
Roche, PC ;
Nascimento, AG .
HISTOPATHOLOGY, 2002, 40 (06) :556-562
[3]   Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J].
Banerjee, S. ;
Reis-Filho, J. S. ;
Ashley, S. ;
Steele, D. ;
Ashworth, A. ;
Lakhani, S. R. ;
Smith, I. E. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (07) :729-735
[4]   Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression [J].
Barnes, PJ ;
Boutilier, R ;
Chiasson, D ;
Rayson, D .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 91 (02) :173-178
[5]   Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer [J].
Cappuzzo, F ;
Hirsch, FR ;
Rossi, E ;
Bartolini, S ;
Ceresoli, GL ;
Bemis, L ;
Haney, J ;
Witta, S ;
Danenberg, K ;
Domenichini, I ;
Ludovini, V ;
Magrini, E ;
Gregorc, V ;
Doglioni, C ;
Sidoni, A ;
Tonato, M ;
Franklin, WA ;
Crino, L ;
Bunn, PA ;
Varella-Garcia, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09) :643-655
[6]   An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast [J].
Dunne, B ;
Lee, AHS ;
Pinder, SE ;
Bell, JA ;
Ellis, IO .
HUMAN PATHOLOGY, 2003, 34 (10) :1009-1015
[7]   Expression of luminal and basal cytokeratins in human breast carcinoma [J].
El-Rehim, DMA ;
Pinder, SE ;
Paish, CE ;
Bell, J ;
Blamey, R ;
Robertson, JFR ;
Nicholson, RI ;
Ellis, IO .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :661-671
[8]   AN EPITHELIAL AND SPINDLE CELL BREAST-TUMOR OF MYOEPITHELIAL ORIGIN - AN IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY [J].
ENGHARDT, MH ;
HALE, JH .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1989, 416 (02) :177-184
[9]  
Fulford LG, 2004, PATHOL INT, V54, pA2
[10]   METAPLASTIC BREAST-CARCINOMA INVADING CHEST-WALL [J].
HARB, JM ;
KOMOROWSKI, RA ;
VITALI, CM .
ULTRASTRUCTURAL PATHOLOGY, 1995, 19 (05) :439-443